WASHINGTON, Sept 16 (Reuters) - Boston Scientific Corp won U.S. approval on Thursday to promote three of its implanted cardiac devices for broader use among patients with heart failure. The Food and ...

WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and ...

NEW YORK/CHICAGO, June 23 (Reuters) - Early intervention with Boston Scientific Corp's implantable devices, called cardiac resynchronization therapy, can slow the progression of heart failure, ...

The devices are being recalled due to an increased risk for permanently entering Safety Mode. HealthDay News — Boston Scientific has issued a recall of Accolade pacemaker devices, according to a ...

FILE PHOTO: FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's ...

On Saturday, Boston Scientific Corporation (NYSE:BSX) unveiled three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device ...

For a moment, it appeared Boston Scientific was having a rare bumpy quarter. Executives in April had estimated tariffs would cost the medical device maker with large operations in Minnesota $200 ...

Boston Scientific also foresees future growth in its Watchman business from a planned label expansion and concomitant ...

The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for ...